{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T01:46:08Z","timestamp":1792201568357,"version":"4.4.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2013,1,3]],"date-time":"2013-01-03T00:00:00Z","timestamp":1357171200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1245\/s10434-012-2836-y","type":"journal-article","created":{"date-parts":[[2013,1,2]],"date-time":"2013-01-02T11:47:11Z","timestamp":1357127231000},"page":"1912-1917","source":"Crossref","is-referenced-by-count":31,"title":["The Value of Preoperative Imaging in Small Bowel Neuroendocrine Tumors"],"prefix":"10.1245","volume":"20","author":[{"given":"Fadi S.","family":"Dahdaleh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Lorenzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maheen","family":"Rajput","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer C.","family":"Carr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junlin","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuf","family":"Menda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"O\u2019Dorisio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Howe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,1,3]]},"reference":[{"key":"2836_CR1","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/cncr.11105","volume":"97","author":"IM Modlin","year":"2003","unstructured":"Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer. 2003;97:934\u201359.","journal-title":"Cancer."},{"key":"2836_CR2","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","volume":"26","author":"JC Yao","year":"2008","unstructured":"Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, et al. One hundred years after \u201ccarcinoid\u201d: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008;26:3063\u201372.","journal-title":"J Clin Oncol."},{"key":"2836_CR3","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1053\/j.gastro.2005.03.038","volume":"128","author":"IM Modlin","year":"2005","unstructured":"Modlin IM, Kidd M, Latich I, Zikusoka MN, Shapiro MD. Current status of gastrointestinal carcinoids. Gastroenterology. 2005;128:1717\u201351.","journal-title":"Gastroenterology."},{"key":"2836_CR4","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1245\/s10434-011-1997-4","volume":"19","author":"FS Dahdaleh","year":"2012","unstructured":"Dahdaleh FS, Calva-Cerqueira D, Carr JC, Liao J, Mezhir JJ, O\u2019Dorisio TM, et al. Comparison of clinicopathologic factors in 122 patients with resected pancreatic and ileal neuroendocrine tumors from a single institution. Ann Surg Oncol. 2012;19:966\u2013972.","journal-title":"Ann Surg Oncol."},{"key":"2836_CR5","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s00268-002-6630-z","volume":"26","author":"P Hellman","year":"2002","unstructured":"Hellman P, Lundstrom T, Ohrvall U, Eriksson B, Skogseid B, Oberg K, et al. Effect of surgery on the outcome of midgut carcinoid disease with lymph node and liver metastases. World J Surg. 2002;26:991\u20137.","journal-title":"World J Surg."},{"key":"2836_CR6","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.surg.2006.07.033","volume":"140","author":"B Givi","year":"2006","unstructured":"Givi B, Pommier SJ, Thompson AK, Diggs BS, Pommier RF. Operative resection of primary carcinoid neoplasms in patients with liver metastases yields significantly better survival. Surgery. 2006;140:891\u20137.","journal-title":"Surgery."},{"key":"2836_CR7","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/MPA.0b013e3181ebb2a5","volume":"39","author":"JP Boudreaux","year":"2010","unstructured":"Boudreaux JP, Klimstra DS, Hassan MM, Woltering EA, Jensen RT, Goldsmith SJ, et al. The NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the jejunum, ileum, appendix, and cecum. Pancreas. 2010;39:753\u201366.","journal-title":"Pancreas."},{"key":"2836_CR8","first-page":"63","volume":"41","author":"JC Reubi","year":"1997","unstructured":"Reubi JC. Regulatory peptide receptors as molecular targets for cancer diagnosis and therapy. Q J Nucl Med. 1997;41:63\u201370.","journal-title":"Q J Nucl Med."},{"key":"2836_CR9","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/BF00181765","volume":"20","author":"EP Krenning","year":"1993","unstructured":"Krenning EP, Kwekkeboom DJ, Bakker WH, Breeman WA, Kooij PP, Oei HY, et al. Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med. 1993;20:716\u201331.","journal-title":"Eur J Nucl Med."},{"key":"2836_CR10","doi-asserted-by":"crossref","first-page":"559","DOI":"10.2214\/ajr.182.3.1820559","volume":"182","author":"KM Horton","year":"2004","unstructured":"Horton KM, Kamel I, Hofmann L, Fishman EK. Carcinoid tumors of the small bowel: a multitechnique imaging approach. Am J Roentgenol. 2004;182:559\u201367.","journal-title":"Am J Roentgenol."},{"key":"2836_CR11","first-page":"426","volume":"1","author":"S Oberndorfer","year":"1907","unstructured":"Oberndorfer S. Karzinoide Tumoren des D\u00fcnndarms. Frankf Z Pathol. 1907;1:426\u201332.","journal-title":"Frankf Z Pathol."},{"key":"2836_CR12","first-page":"440","volume":"86","author":"A Scholte","year":"1931","unstructured":"Scholte A. Ein fall von angioma telangiectaticum cutis mit chronischer endocarditis und malignem d\u00fcnndarmcarcinoid. Beitr Pathol Anat. 1931;86:440\u20133.","journal-title":"Beitr Pathol Anat."},{"key":"2836_CR13","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1152\/physrev.1954.34.3.563","volume":"34","author":"IH Page","year":"1954","unstructured":"Page IH. Serotonin (5-hydroxytryptamine). Physiol Rev. 1954;34:563\u201388.","journal-title":"Physiol Rev."},{"key":"2836_CR14","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1056\/NEJM195608092550605","volume":"255","author":"BJ Haverback","year":"1956","unstructured":"Haverback BJ, Sjoerdsma A, Terry LL. Urinary excretion of the serotonin metabolite, 5-hydroxyindoleacetic acid, in various clinical conditions. N Engl J Med. 1956;255:270\u20132.","journal-title":"N Engl J Med."},{"key":"2836_CR15","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1259\/0007-1285-46-552-1016","volume":"46","author":"GN Hounsfield","year":"1973","unstructured":"Hounsfield GN. Computerized transverse axial scanning (tomography). 1. Description of system. Br J Radiol. 1973;46:1016\u201322.","journal-title":"Br J Radiol."},{"key":"2836_CR16","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1677\/ERC-09-0078","volume":"17","author":"DJ Kwekkeboom","year":"2010","unstructured":"Kwekkeboom DJ, Kam BL, van Essen M, Teunissen JJ, van Eijck CH, Valkema R, et al. Somatostatin-receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors. Endoc Relat Cancer. 2010;17:R53\u201373.","journal-title":"Endoc Relat Cancer."},{"key":"2836_CR17","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1046\/j.1365-2141.2001.02583.x","volume":"112","author":"PJ Lugtenburg","year":"2001","unstructured":"Lugtenburg PJ, Krenning EP, Valkema R, Oei HY, Lamberts SW, Eijkemans MJ, et al. Somatostatin receptor scintigraphy useful in stage I\u2013II Hodgkin\u2019s disease: more extended disease identified. Br J Haematol. 2001;112:936\u201344.","journal-title":"Br J Haematol."},{"key":"2836_CR18","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1200\/JCO.2000.18.6.1331","volume":"18","author":"M Raderer","year":"2000","unstructured":"Raderer M, Kurtaran A, Leimer M, Angelberger P, Niederle B, Vierhapper H, et al. Value of peptide receptor scintigraphy using (123)I-vasoactive intestinal peptide and (111)In-DTPA-D-Phe1-octreotide in 194 carcinoid patients: Vienna University experience, 1993 to 1998. J Clin Oncol. 2000;18:1331\u20136.","journal-title":"J Clin Oncol."},{"key":"2836_CR19","first-page":"295","volume":"91","author":"W Shi","year":"1998","unstructured":"Shi W, Johnston CF, Buchanan KD, Ferguson WR, Laird JD, Crothers JG, et al. Localization of neuroendocrine tumours with [111In] DTPA-octreotide scintigraphy (octreoscan): a comparative study with CT and MR imaging. Q J Math. 1998;91:295\u2013301.","journal-title":"Q J Math."},{"key":"2836_CR20","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.jamcollsurg.2010.07.016","volume":"211","author":"AJ Chambers","year":"2010","unstructured":"Chambers AJ, Pasieka JL, Dixon E, Rorstad O. Role of imaging in the preoperative staging of small bowel neuroendocrine tumors. J Am Coll Surg. 2010;211:620\u20137.","journal-title":"J Am Coll Surg."},{"key":"2836_CR21","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1210\/jc.2004-1938","volume":"90","author":"H Orlefors","year":"2005","unstructured":"Orlefors H, Sundin A, Garske U, Juhlin C, Oberg K, Skogseid B, et al. Whole-body (11)C-5-hydroxytryptophan positron emission tomography as a universal imaging technique for neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and computed tomography. J Clin Endocr Metab. 2005;90:3392\u2013400.","journal-title":"J Clin Endocr Metab."},{"key":"2836_CR22","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1007\/s002590100639","volume":"28","author":"M Hofmann","year":"2001","unstructured":"Hofmann M, Maecke H, Borner R, Weckesser E, Schoffski P, Oei L, et al. Biokinetics and imaging with the somatostatin receptor PET radioligand (68)Ga-DOTATOC: preliminary data. Eur J Nucl Med. 2001;28:1751\u20137.","journal-title":"Eur J Nucl Med."},{"key":"2836_CR23","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S1536-1632(03)00038-6","volume":"5","author":"J Kowalski","year":"2003","unstructured":"Kowalski J, Henze M, Schuhmacher J, Macke HR, Hofmann M, Haberkorn U. Evaluation of positron emission tomography imaging using [68Ga]-DOTA-D Phe(1)-Tyr(3)-octreotide in comparison to [111In]-DTPAOC SPECT. First results in patients with neuroendocrine tumors. Mol Imaging Biol. 2003;5:42\u20138.","journal-title":"Mol Imaging Biol."},{"key":"2836_CR24","doi-asserted-by":"crossref","first-page":"508","DOI":"10.2967\/jnumed.106.035667","volume":"48","author":"M Gabriel","year":"2007","unstructured":"Gabriel M, Decristoforo C, Kendler D, Dobrozemsky G, Heute D, Uprimny C, et al. 68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and CT. J Nucl Med. 2007;48:508\u201318.","journal-title":"J Nucl Med."},{"key":"2836_CR25","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.2214\/AJR.11.7298","volume":"197","author":"N Naswa","year":"2011","unstructured":"Naswa N, Sharma P, Kumar A, Nazar AH, Kumar R, Chumber S, et al. Gallium-68-DOTA-NOC PET\/CT of patients with gastroenteropancreatic neuroendocrine tumors: a prospective single-center study. AJR Am J Roentgenol. 2011;197:1221\u20138.","journal-title":"AJR Am J Roentgenol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-012-2836-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-012-2836-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-012-2836-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,7]],"date-time":"2019-07-07T16:38:13Z","timestamp":1562517493000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-012-2836-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,3]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["2836"],"URL":"https:\/\/doi.org\/10.1245\/s10434-012-2836-y","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,3]]}}}